Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate Mofetil in Chronic Graft-Versus-Host Disease
NCT00089141Phase 3Terminated
- Start
- May 2004
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in chronic graft-versus-host disease (cGVHD) comparing Mycophenolate mofetil with Placebo (2 arms). Primary endpoint: Cure of Chronic GVHD Without Resorting to Secondary Systemic Therapy at 2 years. Started May 2004; status: terminated.
02
Drugs
mycophenolate mofetil
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT00089141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00089141.